NEXPOINT ASSET MANAGEMENT, L.P. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$5,515,652
-13.0%
2,495,7700.0%0.80%
+17.3%
Q1 2023$6,339,256
+2853.7%
2,495,770
+2074.6%
0.69%
+3935.3%
Q4 2022$214,620
-27.2%
114,7700.0%0.02%
-15.0%
Q3 2022$295,000
+32.9%
114,7700.0%0.02%0.0%
Q2 2022$222,000
-34.9%
114,7700.0%0.02%
-54.5%
Q1 2022$341,000
-33.9%
114,7700.0%0.04%
-39.7%
Q4 2021$516,000
-59.9%
114,770
-56.7%
0.07%
-67.0%
Q3 2021$1,287,000
-28.7%
264,7700.0%0.22%
-43.9%
Q2 2021$1,806,000
+89.9%
264,770
+96.5%
0.39%
+58.9%
Q1 2021$951,000
+8.4%
134,770
-3.7%
0.25%
-13.9%
Q4 2020$877,000
+15.7%
140,0200.0%0.29%
+68.4%
Q3 2020$758,000
+3.7%
140,0200.0%0.17%
+3.6%
Q2 2020$731,000
+44.2%
140,020
-13.0%
0.16%
+71.9%
Q1 2020$507,000
-87.0%
160,870
-83.4%
0.10%
-67.6%
Q4 2019$3,895,000
-6.7%
966,4930.0%0.30%
+13.8%
Q3 2019$4,176,000966,4930.26%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders